Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Michael Saylor Shuts Down Bitcoin Sale Rumors

Michael Saylor Shuts Down Bitcoin Sale Rumors

CoinomediaCoinomedia2025/11/14 19:36
By:Isolde VerneIsolde Verne

Michael Saylor denies claims that MicroStrategy is selling Bitcoin, reaffirming the company's long-term BTC commitment.Saylor Responds to Bitcoin Sale SpeculationMicroStrategy’s Long-Term Bitcoin StrategyNo Evidence of Selling Activity

  • Michael Saylor denies Bitcoin sale rumors.
  • MicroStrategy remains committed to holding BTC.
  • No evidence supports recent selling speculations.

Saylor Responds to Bitcoin Sale Speculation

Michael Saylor, Executive Chairman of MicroStrategy, has addressed swirling rumors suggesting that the company may be selling its Bitcoin holdings. In a direct statement, Saylor dismissed the speculation, firmly stating that “there is no truth” to the claims.

This clarification comes after several online posts and social media chatter implied that MicroStrategy might be offloading some of its Bitcoin to capitalize on recent market rallies. However, Saylor’s comment quickly put those rumors to rest, reaffirming the company’s consistent “buy and hold” strategy.

MicroStrategy’s Long-Term Bitcoin Strategy

Since initiating its Bitcoin purchases in 2020, MicroStrategy has become the largest corporate holder of Bitcoin, with over 150,000 BTC on its balance sheet. The company has consistently portrayed Bitcoin as a long-term asset and a hedge against inflation, a stance that Saylor has reinforced numerous times.

Despite Bitcoin’s volatility and various market corrections, MicroStrategy has not deviated from its strategy. Each market dip has typically been met with more purchases rather than sales. According to Saylor, this philosophy hasn’t changed—and the company remains committed to its Bitcoin vision.

JUST IN: Michael Saylor says "there is no truth" to rumors of Strategy selling Bitcoin. pic.twitter.com/OavIgGg4gH

— Watcher.Guru (@WatcherGuru) November 14, 2025

No Evidence of Selling Activity

Blockchain analysts and market observers also noted that there is no on-chain evidence suggesting MicroStrategy has moved any significant amount of Bitcoin recently. Saylor’s public response aligns with this data, adding credibility to his denial.

In a market driven by sentiment and speculation, it’s not uncommon for rumors to influence short-term movements. However, MicroStrategy and Saylor have maintained transparency in their Bitcoin holdings, with each major purchase publicly documented. Until any formal SEC filings suggest otherwise, the company’s stance remains clear.

Read Also:

  • Circle Mints $1B USDC After Market Crash
  • BlackRock Moves $387M in BTC & ETH to Coinbase Prime
  • “Bitcoin Is Dead”… Again? History Repeats Itself
  • Tether CEO Calls Market Dip ‘Bitcoin Black Friday’
  • American Bitcoin Doubles Q3 2025 Revenue to $64M
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Bitcoin Updates: Institutional Investors Return and Soft Policy Hints Drive Bitcoin's Significant Recovery

- Bitcoin surged above $89,000 in late November 2025, reversing a six-month low amid institutional reentry and macroeconomic optimism. - Fed rate-cut expectations (84% for December) and $238M Bitcoin ETF inflows fueled dollar weakness and crypto demand. - Coinbase's 22-day negative premium reversed, signaling easing institutional selling pressure and potential trend reversal. - Solana's $145 slump highlighted crypto divergence, while Bitcoin's $100,000 support and open interest dynamics indicated bearish e

Bitget-RWA2025/11/27 17:22
Bitcoin Updates: Institutional Investors Return and Soft Policy Hints Drive Bitcoin's Significant Recovery

Artificial Intelligence Applications in Biomedical Studies and Their Impact on Investment

- AI is revolutionizing drug discovery by accelerating timelines and reducing costs in pharmaceutical R&D. - Companies like Insilico Medicine and Exscientia use AI to cut drug development cycles by 70% and reduce compound testing, advancing candidates to clinical trials rapidly. - The AI-driven biotech market is projected to reach $350–410 billion annually by 2025, offering investment opportunities in AI-native firms and infrastructure providers. - However, regulatory challenges and the lack of approved AI

Bitget-RWA2025/11/27 17:22
Artificial Intelligence Applications in Biomedical Studies and Their Impact on Investment

Internet Computer’s Latest Rally: Driven by Network Enhancements and Growing Institutional Interest

- Internet Computer (ICP) surged in 2025 due to technical upgrades, institutional partnerships, and speculative trading. - Fission/Stellarator boosted capacity by 50%, while Meridian/Flux aim to enhance cross-chain interoperability and scalability. - Q3 2025 saw $1.14B trading volume but 22.4% DApp engagement drop, highlighting infrastructure-user adoption disconnect. - TVL discrepancies ($237B vs. $1.14B) and reliance on institutional capital raise sustainability concerns amid inflated metrics. - Partners

Bitget-RWA2025/11/27 17:22
Internet Computer’s Latest Rally: Driven by Network Enhancements and Growing Institutional Interest